Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.
Sandroni
Paola
P
Autonomic Disorders Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. psandroni@mayo.edu
Opfer-Gehrking
Tonette L
TL
Singer
Wolfgang
W
Low
Phillip A
PA
D000368:Aged; D001342:Autonomic Nervous System Diseases / Q000150:complications / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011729:Pyridostigmine Bromide / Q000008:administration & dosage*; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D011729:Pyridostigmine Bromide